Molecular cloning and functional expression of the mouse CRF2(a) receptor splice variant

Regulatory Peptides

Volumn 121, Issue 1-3, 2004, Pages 89-97

  Dautzenberg, Frank M ^a,c   Higelin, Jacqueline ^a   Wille, Sandra ^b   Brauns, Olaf ^b,d  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^d FRESENIUS MEDICAL CARE   (Germany)

Author keywords

cAMP stimulation; Ligand binding; Receptor cloning; Receptor expression; Tissue distribution

Indexed keywords

AMINO ACID DERIVATIVE; COMPLEMENTARY DNA; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYCLIC AMP; MESSENGER RNA; POLYPEPTIDE; UROTENSIN I;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN CORTEX; CONTROLLED STUDY; HEART; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; STIMULATION; TELENCEPHALON; TISSUE DISTRIBUTION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BRAIN; CELL LINE; CLONING, MOLECULAR; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP; GENE EXPRESSION PROFILING; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN BINDING; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SEQUENCE ALIGNMENT; TRANSFECTION; UROTENSINS;

MAMMALIA;

EID: 3142604662     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2004.04.009     Document Type: Article

References (64)

1. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science. 213:1981;1394-1397
2. Smagin G.N., Dunn A.J. The role of CRF receptor subtypes in stress-induced behavioural responses. Eur. J. Pharmacol. 405:2000;199-206
3. Arborelius L., Owens M.J., Plotsky P.M., Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 160:1999;1-12
4. Dautzenberg F.M., Hauger R.L. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci. 23:2002;71-77
5. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., et al. Urocortin, a mamalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 378:1995;287-292
6. Hsu S.Y., Hsueh A.J.W. Human stresscopin and stresscopin-related peptide are selective ligands for the corticotropin-releasing hormone receptor. Nat. Med. 7:2001;605-611
7. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., Donaldson C., et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U. S. A. 98:2001;7570-7575
8. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., et al. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. U. S. A. 98:2001;2843-2848
9. Dautzenberg F.M., Kilpatrick G.J., Hauger R.L., Moreau J.L. Molecular biology of the CRH receptors - in the mood. Peptides. 22:2001;753-760
10. Hauger R.L., Grigoriadis D.E., Dallman M.F., Plotsky P.M., Vale W.W., Dautzenberg F.M. International union of pharmacology: XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacol. Rev. 55:2003;21-26
11. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B., et al. Cloning and characterization of a functionally distinct corticotropin releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. U. S. A. 92:1995;836-840
12. Kishimoto T., Pearse R.V. II, Lin C.R., Rosenfeld M.G. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. U. S. A. 92:1995;1108-1112
13. Perrin M., Donaldson C., Chen R., Blunt A., Berggren T., Bilezikjian L., et al. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl. Acad. Sci. U. S. A. 92:1995;2969-2973
14. Stenzel P., Kesterson R., Yeung W., Cone R.D., Rittenberg M.B., Stenzel-Poore M.P. Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol. Endocrinol. 9:1995;637-645
15. Liaw C.W., Lovenberg T.W., Barry G., Oltersdorf T., Grigoriadis D.E., De Souza E.B. Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology. 137:1996;72-77
16. Dautzenberg F.M., Dietrich K., Palchaudhuri M.R., Spiess J. Identification of two corticotropin-releasing factor receptors with high ligand selectivity from Xenopus laevis: unusual pharmacology of the type 1 receptor. J. Neurochem. 69:1997;1640-1649
17. Palchaudhuri M.R., Hauger R.L., Wille S., Fuchs E., Dautzenberg F.M. Isolation and pharmacological characterization of two functional splice variants of corticotropin-releasing factor type 2 receptor from Tupaia belangeri. J. Neuroendocrinol. 11:1999;419-428
18. Arai M., Assil I.Q., Abou-Samra A.B. Characterization of three corticotropin-releasing factor receptors in catfish: a novel third receptor is predominantly expressed in pituitary and urophysis. Endocrinology. 142:2001;446-454
19. Pohl S., Darlison M.G., Clarke W.C., Lederis K., Richter D. Cloning and functional pharmacology of two corticotropin-releasing factor receptors from a teleost fish. Eur. J. Pharmacol. 430:2001;193-202
20. Kilpatrick G.J., Dautzenberg F.M., Martin G.R., Eglen R.M. G-protein coupled receptors - the splicing on the cake. Trends Pharmacol. Sci. 20:1999;294-301
21. 2γ receptor. Mol. Endocrinol. 12:1998;1077-1085
22. Catalano R.D., Kyriakou T., Chen J., Easton A., Hillhouse E.W. Regulation of corticotropin-releasing hormone type 2 receptors by multiple promoters and alternative splicing: identification of multiple splice variants. Mol. Endocrinol. 17:2003;395-410
23. Wille S., Sydow S., Palchaudhuri M.R., Spiess J., Dautzenberg F.M. Identification of amino acids in the N-terminal domain of corticotropin- releasing factor receptor 1 that are important determinants of high affinity ligand binding. J. Neurochem. 72:1999;388-395
24. Dautzenberg F.M., Py-Lang G., Higelin J., Fischer C., Wright M.B., Huber G. Different binding modes of amphibian and human CRF type 1 and type 2 receptors: evidence for evolutionary differences. J. Pharmacol. Exp. Ther. 296:2001;113-120
25. Dautzenberg F.M., Wille S., Lohmann R., Spiess J. Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site. Proc. Natl. Acad. Sci. U. S. A. 95:1998;4941-4946
26. Dautzenberg F.M., Kilpatrick G.J., Wille S., Hauger R.L. The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptors reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile. J. Neurochem. 73:1999;821-829
27. 2α receptors and the role of position 185 for receptor-ligand selectivity. Neuropharmacology. 39:2000;1368-1376
28. Dautzenberg F.M., Higelin J., Brauns O., Butscha B., Hauger R.L. Five amino acids of the Xenopus laevis CRF2 receptor mediate differential binding of CRF ligands in comparison to its human counterpart. Mol. Pharmacol. 61:2002;1132-1139
29. 2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 15:1995;6340-6350
30. Nappi R.E., Rivest S. Stress-induced genetic expression of a selective corticotropin-releasing factor-receptor subtype within the rat ovaries: an effect dependent on the ovulatory cycle. Biol. Reprod. 53:1995;1417-1428
31. Tsai-Morris C.T., Buczko E., Geng Y., Gamboa-Pinto A., Dufeau M.L. The genomic structure of the rat corticotropin releasing factor receptor. J. Biol. Chem. 271:1996;14519-14525
32. Slominski A., Pisarchik A., Tobin D.J., Mazurkiewicz J.E., Wortsman J. Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology. 145:2004;941-950
33. 2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology. 136:1995;4139-4142
34. Crawley J.N. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res. 835:1999;18-26
35. Brauns O., Brauns S., Zimmermann B., Jahn O., Spiess J. Differential responsiveness of CRF receptor subtypes to N-terminal truncation of peptidic ligands. Peptides. 23:2002;881-888
36. 2 receptor mediate differential binding of CRF ligands in comparison to its human counterpart. Mol. Pharmacol. 61:2002;1132-1139
37. Dautzenberg F.M., Py-Lang G., Higelin J., Fischer C., Wright M.B., Huber G. Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences. J. Pharmacol. Exp. Ther. 296:2001;113-120
38. Dautzenberg F.M., Mevenkamp G., Wille S., Hauger R.L. N-terminal splice variants of the type I PACAP receptor: isolation, characterization, and ligand binding/selectivity determinants. J. Neuroendocrinol. 11:1999;941-950
39. Dautzenberg F.M., Hauger R.L. G protein receptor kinase 3 and protein kinase C-mediated desensitization of the PACAP receptor type 1 in human Y-79 retinoblastoma cells. Neuropharmacology. 40:2001;394-407
40. Dautzenberg F.M., Higelin J., Teichert U. Functional characterization of corticotropin-releasing factor type 1 receptor endogenously expressed in human embryonic kidney 293 cells. Eur. J. Pharmacol. 390:2000;51-59
41. Muglia L., Jacobson L., Dikkes P., Majzoub J.A. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature. 373:1995;427-432
42. Smith G.W., Aubry J.M., Dellu F., Contarino A., Bilezikjian L.M., Gold L.H., et al. Corticotropin-releasing factor 1-deficient mice display decreased anxiety, impaired stress response, and abberrant neuroendocrine development. Neuron. 20:1998;1093-1102
43. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J.M., Stalla G.K., et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat. Genet. 19:1998;162-166
44. Bale T.L., Contarino A., Smith G.W., Chan R., Gold L.H., Sawchenko P.E., et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat. Genet. 24:2000;410-414
45. Coste S.C., Kesterson R.A., Heldwein K.A., Stevens S.L., Heard A.D., Hollis J.H., et al. Abnormal adaptions to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat. Genet. 24:2000;403-409
46. Kishimoto T., Radulovic J., Radulovic M., Lin C.R., Schrick C., Hooshmand F., et al. Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat. Genet. 24:2000;415-419
47. Lovenberg T.W., Chalmers D.T., Liu C., De Souza E.B. CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology. 136:1995;4139-4142
48. van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 428:2000;191-212
49. Segal M.M. Transport of nutrients across the choroid plexus. Microsc. Res. Tech. 52:2001;38-48
50. Spina M., Merlo-Pich E., Chan R.K., Basso A.M., Rivier J., Vale W., et al. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science. 273:1996;1561-1564
51. Raduolovic J., Kammermeyer J., Spiess J. Relationship between Fos production and classical fear conditioning: effects of novelty, latent inhibition, and unconditioned stimulus preexposure. J. Neurosci. 18:1998;7452-7461
52. Lee K.H., Bishop G.A., Tian J.B., King J.S. Evidence for an axonal localization of the type 2 corticotropin-releasing factor receptor during postnatal development of the mouse cerebellum. Exp. Neurol. 187:2004;11-22
53. Takahashi L.K., Ho S.P., Livanov V., Graciani N., Arneric S.P. Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety. Brain Res. 902:2001;135-142
54. Pelleymounter M.A., Joppa M., Ling N., Foster A.C. Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress. J. Pharmacol. Exp. Ther. 302:2002;145-152
55. Bakshi V.P., Smith-Roe S., Newman S.M., Grigoriadis D.E., Kalin N.H. Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala. J. Neurosci. 22:2002;2926-2935
56. Risbrough V.B., Hauger R.L., Pelleymounter M.A., Geyer M.A. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology (Berl). 170:2003;178-187
57. Valdez G.R., Zorrilla E.P., Rivier J., Vale W.W., Koob G.F. Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist. Brain Res. 980:2003;206-212
58. Valdez G.R., Inoue K., Koob G.F., Rivier J., Vale W., Zorrilla E.P. Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide. Brain Res. 943:2002;142-150
59. Hammack S.E., Pepin J.L., DesMarteau J.S., Watkins L.R., Maier S.F. Low doses of corticotropin-releasing hormone injected into the dorsal raphe nucleus block the behavioral consequences of uncontrollable stress. Behav. Brain Res. 147:2003;55-64
60. Perrin M.H., Sutton S.W., Cervini L.A., Rivier J.E., Vale W.W. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors. J. Pharmacol. Exp. Ther. 288:1999;729-734
61. Rühmann A., Bonk I., Kopke A.K. High-affinity binding of urocortin and astressin but not CRF to G protein-uncoupled CRFR1. Peptides. 20:1999;1311-1319
62. Ruhmann A., Bonk I., Lin C.R., Rosenfeld M.G., Spiess J. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2β-selective antisauvagine-30. Proc. Natl. Acad. Sci. U. S. A. 95:1998;15264-15269
63. 123I-K31440 as a potential SPECT ligand. Peptides. 23:2002;453-460
64. Ozawa M., Oki Y., Watanabe F., Iino K., Masuzawa M., Iwabuchi M., et al. Effect of urocortin and its interaction with adrenocorticotropin (ACTH) secretagogues on ACTH release. Peptides. 19:1998;513-518